December 20, 2025 06:39 am (IST)
GlaxoSmithKline records 11% growth for Q2
New Delhi, Nov 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the second quarter ended September 30, 2014.
The company's net sales were reported at Rs 1075 crores, which recorded a growth of 11% over 2013 with PAT at Rs. 160 crores growing by 9% for the same period and PBT at Rs 245 crores growing by 10%.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are delighted to have delivered consistent growth as the category leader. The consumer sentiments are showing early signs of recovery and our brands are well poised to help consumers do more, feel better and live longer. Our relentless focus on science, innovation and customer, remains our key differentiator and helps us to stay ahead in the category."
"We continue to improve consumer’s experience with new products like the re-launched Horlicks with proven health benefits, ‘instantization’ and new positioning, highlighting its daily nutritional relevance. We also remain focused on our access strategy to ensure that our products are within the easy reach of our large consumer base,” Ahmed said.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Tata AIA launches multicap opportunities fund
Fri, Dec 19 2025
IPO fireworks! ICICI Prudential AMC pops 20% on market debut
Fri, Dec 19 2025
Bharti Airtel announces top leadership changes; Gopal Vittal to become Executive Vice Chairman
Thu, Dec 18 2025
TCS bets big on AI, shares spike as company reveals ambitious plan
Thu, Dec 18 2025
Meesho’s wild ride: Hits record market cap, then suddenly slides
Thu, Dec 18 2025
SBI rolls out YONO 2.0! Banking gets a major digital upgrade
Wed, Dec 17 2025
Nephrocare IPO pops on debut, dialysis major lists at 7% premium
Wed, Dec 17 2025
